Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-technology-1/hologic-announces-fourth-quarter-and-fiscal-2009-operating-results-6111-21/;+health+history;+medical+history.html) was not found.

Search medicine technology 1 hologic announces fourth quarter and fiscal 2009 operating results 6111 21 ;+health+history;+medical+history html at Google

Search medicine technology 1 hologic announces fourth quarter and fiscal 2009 operating results 6111 21 ;+health+history;+medical+history html at Yahoo

Search medicine technology 1 hologic announces fourth quarter and fiscal 2009 operating results 6111 21 ;+health+history;+medical+history html at Msn

Google
 
Breaking Biology News(10 mins):New inherited eye disease discovered 2Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4Experts: Disease-resistant plants enhance profits, client satisfaction 2Olympus Managed Health Care Nominated for Prestigious International Award 57106 1Olympus Managed Health Care Nominated for Prestigious International Award 57106 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 1American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 1Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 2Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 4Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 5
Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 1H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 2H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 3Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept 29 14029 1Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept 29 14029 2PolyOne Presented with Frost 26 Sullivan Medical Product Award 57096 1PolyOne Presented with Frost 26 Sullivan Medical Product Award 57096 2